Zobrazeno 1 - 10
of 87
pro vyhledávání: '"H Tveit"'
Autor:
Sjur H. Tveit, Peder L. Myhre, Tove Aminda Hanssen, Signe Helene Forsdahl, Amjid Iqbal, Torbjørn Omland, Henrik Schirmer
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-9 (2022)
Abstract To compare the performance of high-sensitivity cardiac troponin I and T (hs-cTnI; hs-cTnT) in diagnosing obstructive coronary artery disease (CAD50) in patients with suspected chronic coronary syndrome (CCS). A total of 706 patients with sus
Externí odkaz:
https://doaj.org/article/6f0d09c4c88f4506b522371a3b00a079
Publikováno v:
Expert Review of Molecular Diagnostics. :1-10
Current trends in management of hyperglycaemia in surgical patients with diabetes mellitus: a review
Autor:
Vladimir N. Kuklin, J. Matri, N. P. Barlow, S. H. Tveit, J. E. Kvernberg, E. -M. Ringvold, V. Dahl
Publikováno v:
Annals of Critical Care. :33-47
A large amount of clinical evidences demonstrates a clear association between long-term and/or stress-related hyperglycaemia, and development of complications after surgery. The incidences of perioperative hyperglycaemia are demonstrated in 20–80 %
Autor:
Peder L. Myhre, Are A. Kalstad, Sjur H. Tveit, Kristian Laake, Erik B. Schmidt, Pal Smith, Dennis W.T. Nilsen, Arnljot Tveit, Svein Solheim, Harald Arnesen, Ingebjørg Seljeflot
Publikováno v:
Journal of Internal Medicine
Myhre, P L, Kalstad, A A, Tveit, S H, Laake, K, Schmidt, E B, Smith, P, Nilsen, D W T, Tveit, A, Solheim, S, Arnesen, H & Seljeflot, I 2022, ' Changes in eicosapentaenoic acid and docosahexaenoic acid and risk of cardiovascular events and atrial fibrillation : A secondary analysis of the OMEMI trial ', Journal of Internal Medicine, vol. 291, no. 5, pp. 637-647 . https://doi.org/10.1111/joim.13442
Myhre, P L, Kalstad, A A, Tveit, S H, Laake, K, Schmidt, E B, Smith, P, Nilsen, D W T, Tveit, A, Solheim, S, Arnesen, H & Seljeflot, I 2022, ' Changes in eicosapentaenoic acid and docosahexaenoic acid and risk of cardiovascular events and atrial fibrillation : A secondary analysis of the OMEMI trial ', Journal of Internal Medicine, vol. 291, no. 5, pp. 637-647 . https://doi.org/10.1111/joim.13442
BACKGROUND: The cardiovascular benefit from n-3 polyunsaturated fatty acids (PUFAs) after acute myocardial infarction (AMI) is controversial, and the importance of serum eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) concentrations for cl
Autor:
P Myhre, T Berge, A Kalstad, S H Tveit, K Laake, E B Schmidt, S Solheim, H Arnesen, I Seljeflot, A Tveit
Publikováno v:
European Heart Journal. 43
Background Findings from recent clinical outcome trials have raised concerns regarding potential off target adverse effects from supplementation with n-3 polyunsaturated fatty acids (PUFA) on atrial fibrillation (AF) risk. Purpose We aimed to assess
Autor:
Ingebjørg Seljeflot, Sjur H Tveit, Paal Smith, Omemi Investigators, Svein Solheim, Harald Arnesen, Dennis W.T. Nilsen, Morten W. Fagerland, Peder L. Myhre, Arnljot Tveit, Erik Berg Schmidt, Kristian Laake, Are A Kalstad
Publikováno v:
Circulation
Kalstad, A A, Myhre, P L, Laake, K, Tveit, S H, Schmidt, E B, Smith, P, Nilsen, D W T, Tveit, A, Fagerland, M W, Solheim, S, Seljeflot, I, Arnesen, H & OMEMI investigators 2021, ' Effects of n-3 Fatty Acid Supplements in Elderly Patients after Myocardial Infarction : A Randomized Controlled Trial ', Circulation, vol. 143, no. 6, pp. 528–539 . https://doi.org/10.1161/CIRCULATIONAHA.120.052209
528–539
Kalstad, A A, Myhre, P L, Laake, K, Tveit, S H, Schmidt, E B, Smith, P, Nilsen, D W T, Tveit, A, Fagerland, M W, Solheim, S, Seljeflot, I, Arnesen, H & OMEMI investigators 2021, ' Effects of n-3 Fatty Acid Supplements in Elderly Patients after Myocardial Infarction : A Randomized Controlled Trial ', Circulation, vol. 143, no. 6, pp. 528–539 . https://doi.org/10.1161/CIRCULATIONAHA.120.052209
528–539
Background: High intake of marine n-3 polyunsaturated fatty acids (PUFA) has been associated with reduced risk of cardiovascular events; however, this has not been confirmed in patients with a recent acute myocardial infarction (AMI). Elderly patient
Autor:
Helge Røsjø, Ingebjørg Seljeflot, Torbjørn Omland, Ragnhild Røysland, Sjur H Tveit, Peder L. Myhre, Tri M. Le, Nils Jakob S. Hoff, Arne Didrik Høiseth
Publikováno v:
Clinical Biochemistry. 78:10-17
Background Cardiac troponins (cTn) are essential in the diagnostic assessment of non-ST-segment-elevation acute coronary syndrome (NSTE-ACS). Elevated concentrations of cTnT and cTnI predict cardiovascular events in non-acute settings, but the indivi
Autor:
Ingebjørg Seljeflot, Erik Berg Schmidt, Sjur H Tveit, Harald Arnesen, Peder L. Myhre, Arnljot Tveit, Kristian Laake, Trine Baur Opstad, Are A Kalstad, Svein Solheim
Publikováno v:
BMC Geriatrics, Vol 19, Iss 1, Pp 1-9 (2019)
Kalstad, A A, Tveit, S, Myhre, P L, Laake, K, Opstad, T B, Tveit, A, Schmidt, E B, Solheim, S, Arnesen, H & Seljeflot, I 2019, ' Leukocyte telomere length and serum polyunsaturated fatty acids, dietary habits, cardiovascular risk factors and features of myocardial infarction in elderly patients ', BMC Geriatrics, vol. 19, no. 1, 376 . https://doi.org/10.1186/s12877-019-1383-9
BMC Geriatrics
Kalstad, A A, Tveit, S, Myhre, P L, Laake, K, Opstad, T B, Tveit, A, Schmidt, E B, Solheim, S, Arnesen, H & Seljeflot, I 2019, ' Leukocyte telomere length and serum polyunsaturated fatty acids, dietary habits, cardiovascular risk factors and features of myocardial infarction in elderly patients ', BMC Geriatrics, vol. 19, no. 1, 376 . https://doi.org/10.1186/s12877-019-1383-9
BMC Geriatrics
BackgroundTelomeres are non-coding sequences at the end of eukaryote chromosomes, which in complex with associated proteins serve to protect subtelomeric DNA. Telomeres shorten with each cell division, are regarded as a biomarker for aging and have a
Autor:
Peder L. Myhre, Omemi, Dennis W.T. Nilsen, E B Smith, Svein Solheim, Harald Arnesen, Kristian Laake, Pål Smith, A A Kalstad, Arnljot Tveit, Ingebjørg Seljeflot, Sjur H Tveit
Publikováno v:
European Heart Journal. 42
Background In the OMEMI trial, elderly post-MI patients did not achieve reduction in cardiovascular events from supplementation of 1.8g n-3 polyunsaturated fatty acids (PUFA). In two recent trials of hypertriglyceridaemic patients the REDUCE-IT trial
Autor:
Kjetil Thorsen, Christian Lund, Jo Røislien, Karianne Larsen, Kristi G. Bache, Volker Solyga, Maren Ranhoff Hov, Lars H Tveit, Henriette S Jaeger
Publikováno v:
European Journal of Neurology
Background: Acute stroke treatment in mobile stroke units (MSU) is feasible and reduces time-to-treatment, but the optimal staffing model is unknown. We wanted to explore if integrating thrombolysis of acute ischemic stroke (AIS) in an anesthesiologi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3086ff48fdb8cf6561b4bbe1c35e5a6b
https://hdl.handle.net/11250/2786635
https://hdl.handle.net/11250/2786635